A Phase II Study of CLAG Regimen Combined With Imatinib Mesylate for Relapsed or Refractory Acute Myeloid Leukemia

Autor: Mirza, Abu-Sayeef, Lancet, Jeffrey E., Sweet, Kendra, Padron, Eric, Pinilla-Ibarz, Javier, Nardelli, Lisa, Cubitt, Christopher, List, Alan F., Komrokji, Rami S.
Zdroj: In Clinical Lymphoma Myeloma and Leukemia December 2017 17(12):902-907
Databáze: ScienceDirect
Externí odkaz: